Stock Quotes in this Article: GERN, HEB, ROSG

MADISON, Wis. (Stockpickr) -- At Stockpickr, we track daily portfolios of stocks that are the biggest percentage gainers and the biggest percentage losers.

Stocks that are making large moves like these are favorites among short-term traders because they can jump into these names and try to capture some of that massive volatility. Stocks that are making big-percentage moves either up or down are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release. Sometimes stocks making big moves have been hit with an analyst upgrade or an analyst downgrade.

>>5 Stocks Set to Soar on Bullish Earnings

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining technical indicators with fundamental trends, discipline and sound money management, you will be well on your way to investment success.

With that in mind, let's take a closer look at a several stocks under $10 that are making large moves to the upside today.

>>5 Breakout Stocks Ready to Surge Higher

Hemispherx Biopharma

Hemispherx Biopharma (HEB) is a specialty pharmaceutical company engaged in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders. This stock is trading up 6.3% to 23 cents per share in recent trading.

Today's Range: $0.22-$0.24

52-Week Range: $0.18-$1.10

Volume: 1.77 million

Three-Month Average Volume: 550,997

>>4 Health Care Stocks Under $10 to Watch

From a technical perspective, HEB is ripping higher here right off its 50-day moving average at 22 cents with heavy upside volume. This stock has been trading inside of a consolidation pattern for the last four months, with shares moving between 19 cents on the downside and 26 cents on the upside. Shares of HEB are now quickly moving within range of triggering a major breakout trade above the upper-end of its recent sideways chart pattern. That breakout will hit if HEB manages to clear some near-term overhead resistance levels at 24 to 26 cents with high volume.

Traders should now look for long-biased trades in HEB as long as it's trending above its 50-day at 22 cents, and then once it sustains a move or close above those breakout levels with volume that hits near or above 550,997 shares. If that breakout triggers soon, then HEB will set up to re-test or possibly take out its next major overhead resistance levels at 35 cents to its 200-day moving average at 45 cents.

Geron

Geron (GERN) develops therapeutic products for cancer that inhibit telomerase. This stock is trading up 3.1% to $1.16 in recent trading.

Today's Range: $1.13-$1.16

52-Week Range: $0.91-$2.99

Volume: 275,000

Three-Month Average Volume: 767,800

>>5 Rocket Stocsk to Buy in June

From a technical perspective, GERN is bouncing higher here right off its 50-day moving average at $1.12 with lighter-than-average volume. This move is quickly pushing shares of GERN within range of triggering a major breakout trade. That trade will hit if GERN manages to take out some near-term overhead resistance levels at $1.20 to $1.22 and then once it clears more resistance at $1.25 with high volume.

Traders should now look for long-biased trades in GERN as long as it's trending above its 50-day at $1.12 or above some more key near-term support at $1.05, and then once it sustains a move or close above those breakout levels with volume that hits near or above 767,800 shares. If that breakout triggers soon, then GERN will set up re-test or possibly take out its next major overhead resistance levels at $1.40 to its 200-day moving average at $1.45. Any high-volume move above $1.45 to $1.51 will then put its next major overhead resistance levels at $1.78 to $1.83 into range for shares of GERN.

Rosetta Genomics

Rosetta Genomics (ROSG) develops diagnostic tests and therapeutic tools. This stock is trading up 10.2% to $4.02 in recent trading.

Today's Range: $3.73-$4.22

52-Week Range: $3.09-$17.35

Volume: 1.43 million

Three-Month Average Volume: 267,956

>>5 Hated Earnings Stocks That Deserve Your Love

Shares of ROSG are ripping higher today after the company announced plans to expand its U.S. commercial footprint from five sales territories currently to 12 territories beginning in July. The company also reported the successful launch of its new corporate and product branding at the recent American Society of Clinical Oncology Annual Meeting.

From a technical perspective, ROSG is soaring higher her right off its 50-day moving average at $3.74 with heavy upside volume. This move is quickly pushing shares of ROSG within range of triggering a near-term breakout trade. That trade will hit if ROSG manages to take out some near-term overhead resistance at $4.15 with high volume. At last check, ROSG has started to flirt with that breakout since the stock has hit an intraday high of $4.22 and volume is well above its three-month average action of 267,956 shares.

Traders should now look for long-biased trades in ROSG as long as it's trending above its 50-day at $3.74 or above some more key near-term support at $3.62 and then once it sustains a move or close above $4.15 to $4.22 with volume that hits near or above 267,956 shares. If that breakout triggers soon, then ROSG will set up to re-test or possibly take out its next major overhead resistance levels at its 200-day moving average of $4.65 to $4.70. Any high-volume move above those levels will then put its next major overhead resistance levels at $5.25 to $5.50, or even $6 into range for shares of ROSG.

To see more stocks that are making notable moves higher today, check out the Stocks Under $10 Moving Higher portfolio on Stockpickr.

-- Written by Roberto Pedone in Madison, Wis.

RELATED LINKS:

>>3 Homebuilders Ready to Fall Down
>>4 Stocks Rising on Unusual Volume

>>5 Big Stocks to Sell Now

Follow Stockpickr on Twitter and become a fan on Facebook.

At the time of publication, author had no positions in stocks mentioned.

Roberto Pedone, based out of Madison, Wis., is an independent trader who focuses on technical analysis for small- and large-cap stocks, options, futures, commodities and currencies. Roberto studied international business at the Milwaukee School of Engineering, and he spent a year overseas studying business in Lubeck, Germany. His work has appeared on financial outlets including CNBC.com and Forbes.com. You can follow Pedone on Twitter at www.twitter.com/zerosum24 or @zerosum24.